Evidence map›Paper›PMID 36642764›Full record

ArticleScientific reports2023

Obstructive sleep apnea is related to alterations in fecal microbiome and impaired intestinal barrier function.

Qianjun Li, Ting Xu, Chuan Shao, Wenhui Gao, Mingming Wang, Yongquan Dong, Xiumin Wang, Feijie Lu, Danqing Li, Huanyu Tan and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Qianjun LiDepartment of Respiratory and Critical Medicine, Ningbo Yinzhou No. 2 Hospital, Ningbo, 315192, Zhejiang Province, China. qqjun8@163.com.
Ting XuSleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510600, China.
Chuan ShaoDepartment of Pulmonary and Critical Care Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo, China.
Wenhui GaoDepartment of Cardiovascular, Hangzhouwan Hospital, Ningbo, Zhejiang Province, China.
Mingming WangDepartment of Respiratory and Critical Medicine, Ningbo Yinzhou No. 2 Hospital, Ningbo, 315192, Zhejiang Province, China.
Yongquan DongDepartment of Respiratory and Critical Medicine, Ningbo Yinzhou No. 2 Hospital, Ningbo, 315192, Zhejiang Province, China.
Xiumin WangSchool of Pharmacy, Hangzhou Medical College, Hangzhou, China.
Feijie LuDepartment of Respiratory and Critical Medicine, Ningbo Yinzhou No. 2 Hospital, Ningbo, 315192, Zhejiang Province, China.
Danqing LiSleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510600, China.
Huanyu TanSleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510600, China.
Yin JiangSleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510600, China.
Qinge XieSleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510600, China.
Fengbo CaiDepartment of High-Throughput, Guangzhou Huayin Health Medical Group Co., Ltd, Guangzhou, China.
Lijie FengSleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510600, China.
Taoping LiSleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510600, China. taoge2@yeah.net.
Nanfang Hospital · CNSouthern Medical University · CNNingbo No. 2 Hospital · CNFirst Affiliated Hospital of Soochow University · CNHangzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive Sleep Apnea (OSA) is related to repeated upper airway collapse, intermittent hypoxia, and intestinal barrier dysfunction. The resulting damage to the intestinal barrier may affect or be affected by the intestinal microbiota. A prospective case-control was used, including 48 subjects from Sleep Medicine Center of Nanfang Hospital. Sleep apnea was diagnosed by overnight polysomnography. Fecal samples and blood samples were collected from subjects to detect fecal microbiome composition (by 16S rDNA gene amplification and sequencing) and intestinal barrier biomarkers-intestinal fatty acid-binding protein (I-FABP) and D-lactic acid (D-LA) (by ELISA and colorimetry, respectively). Plasma D-LA and I-FABP were significantly elevated in patients with OSA. The severity of OSA was related to differences in the structure and composition of the fecal microbiome. Enriched Fusobacterium, Megamonas, Lachnospiraceae_UCG_006, and reduced Anaerostipes was found in patients with severe OSA. Enriched Ruminococcus_2, Lachnoclostridium, Lachnospiraceae_UCG_006, and Alloprevotella was found in patients with high intestinal barrier biomarkers. Lachnoclostridium and Lachnospiraceae_UCG_006 were the common dominant bacteria of OSA and intestinal barrier damage. Fusobacterium and Peptoclostridium was independently associated with apnea-hypopnea index (AHI). The dominant genera of severe OSA were also related to glucose, lipid, neutrophils, monocytes and BMI. Network analysis identified links between the fecal microbiome, intestinal barrier biomarkers, and AHI. The study confirms that changes in the intestinal microbiota are associated with intestinal barrier biomarkers among patients in OSA. These changes may play a pathophysiological role in the systemic inflammation and metabolic comorbidities associated with OSA, leading to multi-organ morbidity of OSA.

Indexed as

MicrobiotaSleep Apnea, ObstructiveSleep Apnea SyndromesBiomarkersHumansPolysomnographyBiomarkers

Identifiers

PMID36642764
PMCPMC9841009
OpenAlexW4316254180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.